Anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic Human A-1234138 Heavy Chain)

Anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic Human A-1234138 Heavy Chain) Uses, Dosage, Side Effects, Food Interaction and all others data.

Anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic Human A-1234138 Heavy Chain) is under investigation in clinical trial NCT02087904 (A Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis).

Trade Name Anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic Human A-1234138 Heavy Chain)
Generic Lutikizumab
Lutikizumab Other Names Immunoglobulin, anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic human a-1234138 heavy chain), disulfide with synthetic human a-1234138 light chain, dimer, Lutikizumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic Human A-1234138 Heavy Chain)
Anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic Human A-1234138 Heavy Chain)

*** Taking medicines without doctor's advice can cause long-term problems.
Share